Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> GSK Hit With Thalidomide Birth Defect Suit
FDAnews Drug Daily Bulletin
Aug. 13, 2012
| Vol. 9 No. 158
GSK Hit With Thalidomide Birth Defect Suit
A group of 11 plaintiffs sued GlaxoSmithKline and other pharmaceutical companies in Pennsylvania court, alleging they suffered birth defects after their mothers took the morning sickness drug thalidomide in the late 1950s and early 1960s.
Law360
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
New Information Chiefs to Restructure FDA IT Office
FDA: Merck’s Insomnia Drug Effective But Dosage Should Be Dialed Down
California Senate Requires Larger Print for Drug Labels